Multichannel Archives -

Building modern commercialisation strategies requires pharma to find the right balance of old ways and new approaches, says

The post-COVID future of physician sample access and engagement

https://pharmaphorum.com/sales-marketing/covid-physician-pharma-access-engagement/

Sales and Marketing/ Views & Analysis/ Views and analysis

What is modular content and why do pharma marketers need it NOW?

mike.hammerton@pharmaphorum.com digital content, digital marketing, Modular content, Multichannel, omnichannel, pharma marketing, Tag 0 Comment

Modular content is an established practice among digital and content marketers in sectors such as FMCG and retail, who

What is modular content and why do pharma marketers need it NOW?

https://pharmaphorum.com/views-analysis-sales-marketing/what-is-modular-content-and-why-do-pharma-marketers-need-it-now/

Sales and Marketing/ Views & Analysis/ Views and analysis

Designing HCP engagement for the next normal

mike.hammerton@pharmaphorum.com customer experience, HCP engagement, IQVIA, Multichannel, omnichannel, Sales reps 0 Comment

Life sciences companies’ engagement with HCPs has changed significantly in the past 12 months, as the COVID-19 pandemic

Designing HCP engagement for the next normal

https://pharmaphorum.com/views-and-analysis/designing-hcp-engagement-for-the-next-normal/

Sales and Marketing/ Views & Analysis/ Views and analysis

Time to change the channel? The future for customer engagement models

mike.hammerton@pharmaphorum.com commercial strategy, COVID-19, customer engagement, Multichannel, omnichannel, Sarah Rickwood 0 Comment

Sarah Rickwood delves into IQVIA data to find out exactly how pharma’s HCP engagement has changed over COVID-19,

Time to change the channel? The future for customer engagement models

https://pharmaphorum.com/sales-marketing/time-to-change-the-channel-the-future-for-customer-engagement-models/

Digital/ News/ News

Pharma to increase spend on digital marketing – report

Richard Staines digital marketing, marketing, Multichannel 0 Comment

A third of pharma companies will be spending more than half of their marketing budget on digital channels

Pharma to increase spend on digital marketing – report

https://pharmaphorum.com/news/pharma-to-increase-spend-on-digital-marketing-report/

Digital/ Sales and Marketing/ Views & Analysis/ Views & Analysis/ Views and analysis

A pharma guide to digital health, multichannel and digital transformation

Paul Tunnah frontiers health, Multichannel 0 Comment

Paul Tunnah runs through the six key aspects of digital health and how businesses can harness them. It’s that

A pharma guide to digital health, multichannel and digital transformation

https://pharmaphorum.com/views-analysis-sales-marketing/a-pharma-guide-to-digital-health-multichannel-and-digital-transformation/

Digital/ Sales and Marketing/ Views & Analysis/ Views & Analysis/ Views and analysis

Adapting pharma marketing for the evolving consumer journey

mike.hammerton@pharmaphorum.com comms, marketing, Multichannel, Tag, webinar 0 Comment

The pharma customer journey is changing with every “like”, share, review, post and measurable action. The great news

Adapting pharma marketing for the evolving consumer journey

https://pharmaphorum.com/views-analysis-digital/adapting-pharma-marketing-for-the-evolving-consumer-journey/

Deep Dive/ Oncology/ Views & Analysis

Smarter thinking about pharmaceutical marketing

mike.hammerton@pharmaphorum.com Deep Dive: Oncology and ASCO 2019, marketing, Multichannel, patient, Robb DeFilippis, Tag 0 Comment

Robb DeFilippis, from end-to-end global creative production and sourcing partner Tag, discusses how a more effective multichannel pharma

Smarter thinking about pharmaceutical marketing

https://pharmaphorum.com/deep-dive/tag-pharmaceutical-marketing-production/

Nine for 2019 Challenges impacting pharma

Market Access/ R&D/ Sales and Marketing/ Views & Analysis/ Views & Analysis/ Views & Analysis/ Views and analysis

Nine for 2019: Opportunities for pharma

mike.hammerton@pharmaphorum.com 2019, biosimilars, China, gene therapies, industry, Multichannel, NIne for 2019, real world data, RWE 0 Comment

In the last Nine for 2019 article, we reflected on the major challenges that are shaping the pharmaceutical

Nine for 2019: Opportunities for pharma

https://pharmaphorum.com/views-and-analysis/nine-for-2019-opportunities-for-pharma/

Trending

Multichannel

Login